compounded semaglutide (as a substitute for Ozempic or Wegovy) and compounded tirzepatide (as a stand-in for Mounjaro and Zepbound). In 2024, a warning by the U.S. Food and Drug Administration ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

Compounded medications are safe — if you know where the ingredients come from. In this case, we don't. Semaglutide, the first FDA-approved obesity drug since 2014, has been surging in popularity.

Telehealth provider will make its big game debut as the semaglutide shortage continues to sustain the firm’s lower-priced ...

Telehealth prescription company Hims & Hers has a new semaglutide initiative. The program will offer compounded semaglutide to customers starting from $199 a month. The company also plans to sell ...

Telehealth company Hims & Hers is playing offense in a new commercial slated to air during the Super Bowl next month. | Telehealth company Hims & Hers is playing offense in a new commercial slated to ...

Hims & Hers may leverage FDA compounding exemptions to further extend its compounded GLP-1 offerings. Learn why HIMS stock is ...

A multi-million dollar Super Bowl ad from telehealth company Hims and Hers downplays risks and side effects of compounded ...

Websites that sell compounded glucagon-like peptide-1 receptor agonists often partially inform or misinform consumers.

FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...

More than one-third of websites selling their own versions implied the products were the same as the FDA-approved drugs.

Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform ...